Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation-Reference-Cited by-同舟云学术

Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation

Published:2013-10-17 Issue:8 Volume:35 Page:517-524
ISSN:1522-9645
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Ulimoen Sara R.,Enger Steve,Pripp Are Hugo,Abdelnoor Michael,Arnesen Harald,Gjesdal Knut,Tveit Arnljot

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/35/8/517/17153865/eht429.pdf

Reference48 articles.

1. Quality of life, exercise capacity and comorbidity in old patients with permanent atrial fibrillation;Ariansen;J Atrial Fibrillation,2008

2. The effect of atrial fibrillation and the ventricular rate control on exercise capacity;Ostermaier;Clin Cardiol,1997

3. Improvement in exercise performance after successful cardioversion in patients with persistent atrial fibrillation and symptoms of heart failure;Wozakowska-Kaplon;Kardiol Pol,2003

4. Atrial fibrillation is associated with a lower exercise capacity in male chronic heart failure patients;Pardaens;Heart,1997

5. Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study;Knudsen;J Am Coll Cardiol,2005

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction "Twindemic” - Shared Root Causes and Treatment Targets;Heart Rhythm;2024-09

2. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS);European Heart Journal;2024-08-30

3. β-blockades and the risk of atrial fibrillation in patients with cardiovascular diseases;Frontiers in Pharmacology;2024-06-25

4. The heart rate response to the 6‐min walk test in atrial fibrillation patients with or without beta‐blockers: Referring to patients with sinus rhythm;Annals of Noninvasive Electrocardiology;2024-06-14

5. Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation;Cardiology Discovery;2024-05-29